In the present study, propensity-score matching was performed to control for potential confounders of HCC outcomes, and the results consistently indicated a significantly shorter TTR in the NASH-related HCC group relative to the other groups, which validated our discovery. This evidence concerns the gene TTR and metabolic dysfunction-associated steatohepatitis.